Marshall Wace participates in SAB Biotherapeutics financing

Marshall Wace was a participant in this multi-tranche preferred-stock private placement. The source describes new equity issuance; individual investment amounts are not disclosed. Announcement, contingent tranches and closing are distinguished in the source evidence.